Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > SCRN and Financials
View:
Post by Kensin1954 on Apr 13, 2021 4:16pm

SCRN and Financials

Are holding DM back. GBLC is holding it's own with a mini rally today .

If SCRN breaks out and DM is making many $$$ two things will happen.

The stock price will begin to reflect the real value of the company and 

most important TORLIF will return.   I hope these people give TORLIF the incentive to return.

JMHO
Comment by Markhamjohn on Apr 13, 2021 6:41pm
I don't think the emphasis should be in the Covid testing. This is certainly a short term cash cow ( if DM is actually selling any new customers) but this simple product is in a race to the bottom with regard to pricing. The article below suggests $30 US is a fair price for rapid testing, and so the other areas, such as AI, and maybe some of the new ventures will have to carry the SP higher ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities